Singulus Technologies (SNG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
29 Jul, 2026Executive summary
Revenue reached €75.9 million in 2024, up slightly from €73.2 million in 2023, but EBIT remained negative at €-0.7 million, though improved from €-10.1 million the prior year.
The company missed its revised sales and EBIT guidance due to project delays in the Solar and Semiconductor segments, with a key order from China postponed to 2025.
Order intake rose sharply to €77.2 million (2023: €43.1 million), and order backlog stood at €77.4 million at year-end.
The group remains highly dependent on large projects and major customers, especially in China, and faces significant going concern risks if planned payments and new orders are delayed.
Financial highlights
Gross margin improved to 33.6% (2023: 22.3%) due to a favorable product mix.
Net loss for the year was €-5.4 million (2023: €-9.8 million); EPS was €-0.61 (2023: €-1.10).
Cash flow from operating activities was positive at €12.7 million (2023: €-26.3 million), mainly from advance payments.
Total assets decreased to €58.5 million (2023: €71.8 million); equity remained negative at €-50.0 million.
Cash and cash equivalents at year-end were €11.3 million.
Outlook and guidance
2025 sales are forecast at €105–115 million, with EBIT expected in the mid-single-digit million range, driven by the Semiconductor and Life Science segments.
2026 is expected to see a significant revenue increase and EBIT in the low double-digit million range.
The company’s outlook is highly dependent on timely customer payments and securing new major projects; failure to achieve these could threaten its existence.
Latest events from Singulus Technologies
- 2025 saw revenue fall to €48.3M and EBIT to -€11.7M, but 2026 outlook is positive after refinancing.SNG
Q4 202529 Jul 2026 - Q1-2026 delivered robust revenue and EBIT growth, with 2026 sales set to surge on Solar strength.SNG
Q1 202629 Jul 2026 - Order intake doubled and gross margin rose, but sales guidance was cut amid ongoing risks.SNG
Q2 202429 Jul 2026 - Revenue and orders fell, but margin improved; outlook positive amid ongoing risks.SNG
Q1 202529 Jul 2026 - Sales, EBIT, and order intake rose, but liquidity and going concern risks remain.SNG
Q3 202429 Jul 2026 - Revenue and orders fell sharply, resulting in losses and heightened liquidity risks.SNG
Q2 202529 Jul 2026 - Sales, EBIT, and order intake fell sharply; refinancing is critical by mid-2026.SNG
Q3 202529 Jul 2026